Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luis Fayad
Phase I Multidose-Escalation Study of the Anti-Cd19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous Infusion Every 3 Weeks to Patients With Relapsed/Refractory B-Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Targeting WNT Pathway in Mantle Cell Lymphoma-Initiating Cells
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Genomic Profiles and Clinical Outcomes of De Novo Blastoid/Pleomorphic MCL Are Distinct From Those of Transformed MCL
Blood advances
Hematology
Stage I Non-Hodgkin Lymphoma: Difference in Survival Outcome by Primary Extranodal Site of Involvement
British Journal of Haematology
Hematology
Long-Term Outcomes and Mutation Profiling of Patients With Mantle Cell Lymphoma (MCL) Who Discontinued Ibrutinib
British Journal of Haematology
Hematology
Bortezomib-Resistant Nuclear Factor κB Expression in Stem-Like Cells in Mantle Cell Lymphoma
Experimental Hematology
Cancer Research
Genetics
Hematology
Molecular Biology
Cell Biology
Ultra-Low-Dose Radiotherapy for Definitive Management of Ocular Adnexal B-Cell Lymphoma
Head and Neck
Otorhinolaryngology
Ultra–low‐dose Radiotherapy for Definitive Management of Ocular Adnexal B‐cell Lymphoma
Head and Neck
Otorhinolaryngology
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology